Figure 6.

Survival analyses of patients with HCC Survival analyses were performed to estimate the prognosis of patients with HCC. The Kaplan-Meier method was used to compare survival rates between patients undergoing DC-CTL therapy combined with adjuvant strategies (the DC-CTL group) and those undergoing radiotherapy or TACE therapy alone (the control group). *Statistically significant differences (*p<0.05, **p<0.005). a. OS curves and PFS curves for all patients. b. OS curves and PFS curves for the radiotherapy subgroup. c. OS curves and PFS curves for the TACE therapy subgroup.